HeartSciences Inc.
HSCS
$3.75
$0.3710.95%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.40K | 0.00 | 14.70K | 18.60K | 18.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.40K | 0.00 | 14.70K | 18.60K | 18.60K |
| Cost of Revenue | 1.90K | 0.00 | 4.60K | 6.10K | 6.10K |
| Gross Profit | 2.50K | 0.00 | 10.10K | 12.50K | 12.50K |
| SG&A Expenses | 3.97M | 3.81M | 3.50M | 3.53M | 3.44M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.36M | 8.31M | 7.48M | 7.07M | 6.32M |
| Operating Income | -8.35M | -8.31M | -7.47M | -7.05M | -6.31M |
| Income Before Tax | -8.77M | -8.52M | -7.62M | -7.29M | -6.61M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.77 | -8.52 | -7.62 | -7.29 | -6.61 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.77M | -8.52M | -7.62M | -7.29M | -6.61M |
| EBIT | -8.35M | -8.31M | -7.47M | -7.05M | -6.31M |
| EBITDA | -8.32M | -8.27M | -7.43M | -7.02M | -6.28M |
| EPS Basic | -9.44 | -10.31 | -10.74 | -24.39 | -34.98 |
| Normalized Basic EPS | -5.90 | -6.44 | -6.72 | -15.24 | -21.86 |
| EPS Diluted | -9.44 | -10.31 | -10.74 | -24.39 | -34.98 |
| Normalized Diluted EPS | -5.90 | -6.44 | -6.72 | -15.24 | -21.86 |
| Average Basic Shares Outstanding | 3.75M | 3.33M | 2.89M | 2.09M | 1.41M |
| Average Diluted Shares Outstanding | 3.75M | 3.33M | 2.89M | 2.09M | 1.41M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |